ATE511551T1 - Aus lebendigen tumorzellen ausgewählte aptamere und deren verwendung - Google Patents

Aus lebendigen tumorzellen ausgewählte aptamere und deren verwendung

Info

Publication number
ATE511551T1
ATE511551T1 AT05741923T AT05741923T ATE511551T1 AT E511551 T1 ATE511551 T1 AT E511551T1 AT 05741923 T AT05741923 T AT 05741923T AT 05741923 T AT05741923 T AT 05741923T AT E511551 T1 ATE511551 T1 AT E511551T1
Authority
AT
Austria
Prior art keywords
tumor cells
aptamers selected
living tumor
aptamers
living
Prior art date
Application number
AT05741923T
Other languages
English (en)
Inventor
Bertrand Tavitian
Frederic Duconge
Domenico Libri
Franciscis Vittorio De
Laura Cerchia
Original Assignee
Commissariat Energie Atomique
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Commissariat Energie Atomique filed Critical Commissariat Energie Atomique
Application granted granted Critical
Publication of ATE511551T1 publication Critical patent/ATE511551T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6806Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6811Selection methods for production or design of target specific oligonucleotides or binding molecules
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/112Disease subtyping, staging or classification

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Pathology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT05741923T 2004-03-17 2005-03-17 Aus lebendigen tumorzellen ausgewählte aptamere und deren verwendung ATE511551T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0402774A FR2867784B1 (fr) 2004-03-17 2004-03-17 Aptameres selectionnes a partir de cellules vivantes tumorales et leurs applications
PCT/FR2005/000656 WO2005093097A1 (fr) 2004-03-17 2005-03-17 Aptameres selectionnes a partir de cellules vivantes tumorales et leurs applications.

Publications (1)

Publication Number Publication Date
ATE511551T1 true ATE511551T1 (de) 2011-06-15

Family

ID=34896603

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05741923T ATE511551T1 (de) 2004-03-17 2005-03-17 Aus lebendigen tumorzellen ausgewählte aptamere und deren verwendung

Country Status (7)

Country Link
US (1) US20080227735A1 (de)
EP (1) EP1756305B1 (de)
JP (1) JP4807591B2 (de)
AT (1) ATE511551T1 (de)
CA (1) CA2559871A1 (de)
FR (1) FR2867784B1 (de)
WO (1) WO2005093097A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE602004007184T2 (de) 2003-04-17 2008-02-28 Affectis Pharmaceuticals Ag Mittel und Verfahren zur Diagnose und Behandlung affektiver Störungen
EP2078751A1 (de) * 2008-01-11 2009-07-15 Commissariat A L'energie Atomique Spezifische zur Unterdrückung der Zellmigration und -invasion durch Krebszellen erzeugte Aptamere, Verfahren zur Auswahl derartiger Aptamere und ihre Verwendung
ES2535614T3 (es) 2008-07-08 2015-05-13 Oncomed Pharmaceuticals, Inc. Agentes de unión a Notch y antagonistas y métodos de uso de los mismos
EP2159286A1 (de) * 2008-09-01 2010-03-03 Consiglio Nazionale Delle Ricerche Verfahren zur Gewinnung von Oligonucleotid-Aptameren und Verwendungen damit
TWI535445B (zh) 2010-01-12 2016-06-01 安可美德藥物股份有限公司 Wnt拮抗劑及治療和篩選方法
KR101580713B1 (ko) 2010-02-24 2015-12-29 이뮤노젠 아이엔씨 엽산염 수용체 1 항체와 면역접합체 및 이들의 용도
CN102971012B (zh) 2010-03-12 2016-05-04 伊缪诺金公司 Cd37结合分子及其免疫缀合物
ITRM20100537A1 (it) 2010-10-12 2012-04-12 Consiglio Nazionale Ricerche Aptamero inibitore del recettore tirosina chinasi axl per uso in terapia
FR2967423B1 (fr) * 2010-11-12 2017-12-15 Commissariat Energie Atomique Ligand specifique de l'annexine 2
FR2969174B1 (fr) 2010-12-16 2014-03-14 Commissariat Energie Atomique Ligand specifique de la proteine lar
CN102864150B (zh) * 2011-06-03 2013-08-21 湖南大学 一种可识别hcv ns5a蛋白的核酸适体、核酸适体的衍生物及其筛选方法和应用
CN102229932B (zh) * 2011-06-03 2013-02-27 湖南大学 可识别hcv e1e2蛋白的核酸适体、核酸适体的衍生物及其筛选方法和应用
CN102229933A (zh) * 2011-06-03 2011-11-02 湖南大学 可识别hcv ns5a蛋白的核酸适体、核酸适体的衍生物及其筛选方法和应用
CN102766693B (zh) * 2012-07-25 2013-08-28 湖南大学 可用于检测人肝癌细胞株smmc-7721的核酸适体及其筛选方法和应用
WO2014127484A1 (en) * 2013-02-21 2014-08-28 British Columbia Cancer Agency Branch Spike-in control nucleic acids for sample tracking

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6280932B1 (en) * 1990-06-11 2001-08-28 Gilead Sciences, Inc. High affinity nucleic acid ligands to lectins
US5580737A (en) * 1990-06-11 1996-12-03 Nexstar Pharmaceuticals, Inc. High-affinity nucleic acid ligands that discriminate between theophylline and caffeine
CA2327400A1 (en) * 1998-04-06 1999-10-14 Bunsen Rush Laboratories, Inc. Directed evolution biosensors
DE60042021D1 (de) * 1999-07-29 2009-05-28 Gilead Sciences Inc Nukleinsäureliganden für den hepatozytischen wachstumsfaktor/dispersionsfaktor (hgf/sf) und seines c-met rezeptors
WO2002102973A2 (en) * 2001-06-20 2002-12-27 Prochon Biotech Ltd. Antibodies that block receptor protein tyrosine kinase activation, methods of screening for and uses thereof
EP1543158B1 (de) * 2002-07-25 2011-07-13 Archemix Corp. Regulierte aptamer-therapeutika

Also Published As

Publication number Publication date
CA2559871A1 (fr) 2005-10-06
JP2007529213A (ja) 2007-10-25
EP1756305A1 (de) 2007-02-28
FR2867784A1 (fr) 2005-09-23
US20080227735A1 (en) 2008-09-18
WO2005093097A1 (fr) 2005-10-06
JP4807591B2 (ja) 2011-11-02
FR2867784B1 (fr) 2006-06-09
EP1756305B1 (de) 2011-06-01

Similar Documents

Publication Publication Date Title
ATE511551T1 (de) Aus lebendigen tumorzellen ausgewählte aptamere und deren verwendung
NL301145I2 (nl) Tirbanibulin
CY1111714T1 (el) Δεσμευτικες πρωτεϊνες αυξητικου παραγοντα ηπατοκυτταρων (hgf).
ATE526991T1 (de) Zusammensetzungen und ihre verwendungen für die gentherapeutische behandlung von knochenerkrankungen
EA201300242A1 (ru) Фармацевтические композиции, содержащие замещенные ациланилиды
EA200700175A1 (ru) Композиции и способы лечения воспалительных заболеваний
MX2012002927A (es) Anticuerpos humanos de alta afinidad con el receptor activado por proteasa humana-2.
EA200801362A1 (ru) Пиримидинил бензотиофеновые соединения
TR200906131T1 (tr) Aktivin -actrIIa antagonistleri ve göğüs kanserinin tedavi e
EA201000016A1 (ru) Способы и композиции для лечения рака, опухолей и нарушений, связанных с опухолями
ATE540949T1 (de) Substituierte pteridine zur behandlung von entzündlichen erkrankungen
EA201270100A1 (ru) Пиримидиноны в качестве ингибиторов pi3k
CY1113963T1 (el) Φαρμακευτικες συνθεσεις οι οποιες περιλαμβανουν ανταγωνιστες ακτιβινης-actriia και χρηση αυτων στην προληψη η' θεραπευτικη αγωγη πολλαπλου μυελωματος
MX2009008430A (es) Anticuerpos anti-robo4 y sus usos.
EA201290894A1 (ru) Азетидиновые производные пиперидин-4-ила как ингибиторы jak1
CY1112798T1 (el) Ενωσεις διαρυλυδαντοϊνης
EA200700321A1 (ru) Пиразолзамещённые аминогетероарильные соединения в качестве ингибиторов протеинкиназы
ME00380B (me) Amtagonisti aktivin-actriia i primjene za stimulaciju rasta kosti
MX2009008347A (es) Oxabicicloheptanos y oxabicicloheptenos, su preparacion y uso.
EA201170832A1 (ru) Пуриновые соединения
DE602005021970D1 (de) Verwendung von peptidverbindungen zur behandlung von schmerzen durch knochenkrebs, chemotherapie- und nucleosid-bedingten schmerzen
MX2010000098A (es) Derivados de guanina policiclicos y sus metodos de uso.
CY1115975T1 (el) Ταπενταδολη για τη θεραπεια πονου σε αρθριτιδα
BRPI0407234A (pt) Heterociclos substituìdos
CY1116840T1 (el) Χρηση 24-norudca

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties